Entering text into the input field will update the search result below

Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q1 2020 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q1 2020 Results Earnings Conference Call May 4, 2020 8:30 AM ET

Company Participants

Sasha Damouni Ellis - Vice President, Investor Relations and Corporate Communications

Scott Braunstein - Chief Executive Officer

Joe Hulihan - Chief Medical Officer

Edward Smith - Vice President, Chief Financial Officer, Secretary and Treasurer

Conference Call Participants

Marc Goodman - SVB Leerink

Jay Olson - Oppenheimer & Co. Inc.

Alethia Young - Cantor Fitzgerald

Douglas Tsao - H.C. Wainright & Co

Michael Higgins - Ladenburg Thalmann


Greetings and welcome to the Marinus Pharmaceuticals First Quarter 2020 Earnings Call. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.

And it's now my pleasure to introduce your host, Sasha Damouni Ellis, Vice President, Investor Relations. Thank you. You may begin, Ms. Ellis.

Sasha Damouni Ellis

Thank you. With me from Marinus are Dr. Scott Braunstein, Chief Executive Officer; Dr. Joe Hulihan, Chief Medical Officer; and Edward Smith, Chief Financial Officer.

Before we begin, I would like to remind everyone that some of the statements made today could be termed as forward-looking under the securities laws. These forward-looking statements, of course, are subject to certain risks and uncertainties that are associated with our business and covered in part in the company's Form 10-K and 10-Q as filed with the Securities and Exchange Commission.

I will now turn the call over to Scott.

Scott Braunstein

Thank you, Sasha. Good morning, everyone, and welcome to our first quarter 2020 business and financial update. As Sasha mentioned, today on the call, I have with me Dr. Joe Hulihan, Chief Medical Officer, who will provide updates on our clinical progress, and Ed Smith, our Chief Financial Officer who will review our financial statements and the company's cash position. We will be available

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About MRNS

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MRNS

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.